《滬深兩市》上證低開3點 深成創板均低開0.2% 抗病毒概念股走個別
內地昨日(1日)新增本土病例53例,均在內蒙古。人行今日(2日)開展100億元人民幣(下同)逆回購操作,單日淨回籠900億元。人民幣兌美元中間價下調26點。上證深成低開。
上證低開3點或0.1%,報3,573點;深成指低開24點或0.2%,報14,769點;創業板指數低開8點或0.2%,報3,464點。
中資金融股無方向,工行(601398.SH)平開。建行(601939.SH)低開0.4%。寧波銀行(002142.SZ)配股成功獲認購額118.9億元,今早復牌低開0.2%。
抗病毒概念股走個別,尚榮醫療(002551.SZ)低開2%。天瑞儀器(300165.SZ)、西隴科學(002584.SZ)、九安醫療(002432.SZ)高開1.9%-6.3%。(ta/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.